Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: A long-term follow-up study

European Journal of Endocrinology

Volumn 160, Issue 4, 2009, Pages 647-655

  Sereg, Márta ^a   Szappanos, Ágnes ^a   Tóke, Judit ^a   Karlinger, Kinga ^a   Feldman, Karolina ^a   Kaszper, Éva ^a   Varga, Ibolya ^a,b   Gláz, Edit ^a   Rácz, Károly ^a   Tóth, Miklós ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; CORTICOTROPIN; HYDROCORTISONE;

ACUTE HEART INFARCTION; ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CUSHING SYNDROME; ENDOCRINE SYSTEM EXAMINATION; FEMALE; FOLLOW UP; GLUCOSE INTOLERANCE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE; ADRENAL CORTEX TUMOR; BLOOD; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL ADENOMA; ADRENOCORTICOTROPIC HORMONE; ATHEROSCLEROSIS; CUSHING SYNDROME; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 64549126078     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0707     Document Type: Article

References (36)

1. Copeland DM. The incidentally discovered adrenal mass. Annals of Internal Medicine 1983 98 940-945.
2. Milton MD, Gross MD & Shapiro B. Clinically silent adrenal masses. Journal of Clinical Endocrinology and Metabolism 1993 77 885-889.
3. NIH. State-of-the-science statement on management of the clinically inapparent adrenal mass ('incidentaloma'). NIH Consensus and State-of-the-Science Statements 2002 19 1-23.
4. Seppel T & Schlaghecke R. Subclinical hypercorticolism in incidentally detected adrenal adenoma. Deutsche Medizinische Wochenschrift 1996 121 503-507.
5. McLeod MK, ThompsonNW, GrossMD, BardesonAG & Bardeson L. Sub-clinical Cushing's syndrome in patients with adrenal incidentalomas. Pitfalls in diagnosis and management. The American Surgeon 1990 56 398-403.
6. Terzolo M, Osella G, Alí A, Boretta G, Cesario F, Pacotti P & Angeli A. Subclinical Cushing's syndrome in adrenal incidentaloma. Clinical Endocrinology 1998 48 89-97.
7. Luton JP, Martinez M, Coste J & Berthrat J. Outcome in patients with adrenal incidentaloma selected for surgery: analysis of 88 cases investigated in a single clinical center. European Journal of Endocrinology 2000 143 111-117.
8. Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C & Thalassinos N. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clinical Endocrinology 1998 48 627-633.
9. Caplan RH, Strutt PJ & Wickus GG. Subclinical hormone secretion by incidentally discovered adrenal masses. Archives of Surgery 1994 129 291-296.
10. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alí A, Giovagnetti M, Opocher G & Angeli A. A survey on adrenal incidentaloma in Italy, Study group on adrenal tumors of the Italian society of endocrinology. Journal of Clinical Endocrinology and Metabolism 2000 85 637-644.
11. Terzolo M, Osella G, Alí A, Boretta G, Magro GP, Termine A, Pacotti P & Angeli A. Different patterns of steroid secretion in patients with adrenal incidentaloma. Journal of Clinical Endocrinology and Metabolism 1996 81 740-744.
12. Tanabe A, Naruse M, Nishikawa T, Yoshimoto T, Shimizu T, Seki T, Takagi S, Imaki T & Takano K. Autonomy of cortisol secretion in clinically silent adrenal incidentaloma. Hormone and Metabolic Research 2001 33 444-450.
13. Tsagarakis S, Vassiliadi D & Thalassinos N. Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications. Journal of Endocrinological Investigation 2006 29 471-482.
14. Shen WT, Lee J, Kebebew E, Clark OH & Duh QY. Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Archives of Surgery 2006 141 771-774.
15. Tauchmanovà L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S & Lombardi G. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. Journal of Clinical Endocrinology and Metabolism 2002 87 4872-4878.
16. Terzolo M, Pia A, Alí A & Osella G. Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism 2002 87 998-1003.
17. Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E & Gross DJ. Preclinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clinical Endocrinology 1996 44 717-722.
18. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V & Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism 2000 85 1440-1448.
19. Vierhapper H, Heinze G, Gessl A & Exner M. Adrenocortical tumors: prevalence of impaired glucose tolerance and of 'Paradoxal rise' of cortisol during an oral glucose tolerance test. Experimental and Clinical Endocrinology and Diabetes 2003 111 415-420.
20. Garappa GG, Pantanetti P, Arnaldi G, Mantero F & Faloia E. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2001 86 5301-5306.
21. Midorikawa S, Sanada H, Hashimoto S, Suzuki T & Watanabe T. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clinical Endocrinology 2001 54 797-804.
22. Bernini G, Moretti A, Lacconi P, Miccoli P, Nami R, Lucani B & Salvetti A. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. European Journal of Endocrinology 2003 148 213-219.
23. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B & Winkelmann W. Preclinical Cushing's syndrome in adrenal 'incidentalomas': comparison with adrenal Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1992 75 826-832.
24. Fernandez-Real JM, Ricart EN, Simo R, Salinas I & Webb SM. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumors. Clinical Endocrinology 1998 49 53-61.
25. Lazúrová I, Dudásová D, Wagnerová H, Dravecká I & Petrásová D. Adrenal incidentalomas and the metabolic syndrome - are there any differences between adenoma and hyperplasia? Neoplasma 2006 53 324-327.
26. Terzolo M, Bovio S, Pia A, Conton PA, Reimondo G, Dall'Asta C, Bemporad D, Angeli A, Opocher G, Mannelli M, Ambrosi B & Mantero F. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. European Journal of Endocrinology 2005 153 307-315.
27. Erbil Y, Ademoglu E, Özbey N, Barbaros U, Tulumoglu Yanik B, Salmaslioglu A, Bozbora A & Özarmagan S. Evaulation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World Journal of Surgery 2006 30 1665-1671.
28. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M & Lombardi G. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. Journal of Clinical Endocrinology and Metabolism 1999 84 2664-2672.
29. Bennett PH. Impact of the new WHO classification and diagnostic criteria. Diabetes, Obesity and Metabolism 1999 1 1-6.
30. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr & Roccella EJ. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003 42 1206-1252.
31. Széles G, Vokó Z, Jenei T, Kardos L, Pozsai Z, Bajtay A, Papp E, Pásti G, Kósa Zs, Molnár I, Lun K & Ádány R. A preliminary evaluation of a health monitoring prgramme in Hungary. European Journal of Public Health 2005 15 26-32.
32. Reincke M, Fassnacht M, Väth S, Mora P & Allolio B. Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocrine Research 1996 22 757-761.
33. Sirén J, Tervahartiala P, Sivula A & Haapaiainen R. Natural course of adrenal incidentalomas: seven-year follow-up study. World Journal of Surgery 2000 24 579-582.
34. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A & Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism 1999 84 520-526.
35. Libè R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P & Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas. European Journal of Endocrinology 2002 147 489-494.
36. Bülow B, Jansson S, Juhlin C, Steen L, Thorén M, Wahrenberg H, Valdemarsson S, Wängberg B & Ahrén B. Adrenal incidentaloma - follow-up results from a Swedish prospective study. European Journal of Endocrinology 2006 154 419-423.